ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire
Top-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for..
Top-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for..
🌙 Having trouble sleeping? You're not alone. In this ever-busy world, a good night's sleep has become..
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Amino Acids Market (2023-2028) by Product, Raw Material, Livestock in Animal..